Clinical Trial Update: Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer [NA]

View source ↗

Summary

This clinical trial update discusses the potential value of urinary tumor DNA testing for guiding repeat transurethral resection decisions in non-muscle-invasiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Snippet

Sponsor: Tianjin Medical University Second Hospital | Conditions: Bladder Cancer, Liquid Biopsy | NA | Status: RECRUITING